Skip to content
Home/Companies/Biotech/Innate Pharma
IP

Innate Pharma

Biotech·France·Exited 2006·Held 6yr

Innate Pharma is a healthcare / biotech company, headquartered in France.

Entry
2000
Hold
6yr
Exit
2006
Est. EV
–

Who owns Innate Pharma?

Innate Pharma was owned by Sofinnova Partners through Sofinnova Capital VI (2008 vintage) from 2000 to 2006, exited via IPO.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VI · 2008 · Life Sciences VC

Key facts

HQFrance
SectorHealthcare / Biotech
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2006

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

ABIONYX Pharma
Exited 2020
BiotechFrance· 2010
DBV
Exited 2014
BiotechFrance· 2010
Omthera Pharmaceuticals
Exited 2013
BiotechUS· 2010
to
Ablynx NV
Exited 2018
BiotechBelgium· 2008
to
Addex Therapeutics
Exited 2012
BiotechSwitzerland· 2008
Movetis
Exited 2010
BiotechBelgium· 2008
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings